Panaxatriol (Panaxtriol) is a research compound studied for its potential to mitigate radiation-induced myelosuppression. It is utilized in pharmacological and radiobiology research, with investigations in both in vitro cellular models and in vivo animal studies exploring its hematoprotective mechanisms.